Efficacy and safety of regorafenib plus PD-1/PD-L1 inhibitors for metastatic colorectal cancer: a systematic review and meta-analysis

Yan Zhong, Xianhang Li, Siqi Chen, Min Deng

Open source

DOI
10.1186/s12957-026-04536-8
Published
2026-08-10
Container
World Journal of Surgical Oncology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12957-026-04536-8,
  title = {Efficacy and safety of regorafenib plus PD-1/PD-L1 inhibitors for metastatic colorectal cancer: a systematic review and meta-analysis},
  author = {Yan Zhong and Xianhang Li and Siqi Chen and Min Deng},
  year = {2026},
  journal = {World Journal of Surgical Oncology},
  doi = {10.1186/s12957-026-04536-8},
  url = {https://doi.org/10.1186/s12957-026-04536-8}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of regorafenib plus PD-1/PD-L1 inhibitors for metastatic colorectal cancer: a systematic review and meta-analysis
AU  - Yan Zhong
AU  - Xianhang Li
AU  - Siqi Chen
AU  - Min Deng
PY  - 2026
JO  - World Journal of Surgical Oncology
DO  - 10.1186/s12957-026-04536-8
UR  - https://doi.org/10.1186/s12957-026-04536-8
ER  - 

APA

Zhong, Y., Li, X., Chen, S., & Deng, M. (2026). Efficacy and safety of regorafenib plus PD-1/PD-L1 inhibitors for metastatic colorectal cancer: a systematic review and meta-analysis. World Journal of Surgical Oncology. https://doi.org/10.1186/s12957-026-04536-8

Source records